Dolby Laboratories (DLB) Current Deferred Revenue (2009 - 2026)

Dolby Laboratories' Current Deferred Revenue history runs 18 years deep, the most recent figure standing at $38.8 million for Q1 2026.

• Quarterly Current Deferred Revenue fell 1.96% year-over-year to $38.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.8 million (down 1.96% YoY) and the FY2025 annual result came in at $31.4 million, down 0.83% from the prior year.
• Current Deferred Revenue was $38.8 million for Q1 2026 at Dolby Laboratories, up from $37.1 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $39.6 million in Q1 2025 and bottomed at $18.6 million in Q3 2022.
• A 5-year average of $31.2 million and a median of $32.6 million in 2024 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue jumped 72.45% — and 2024, when it slipped 10.76%.
• Dolby Laboratories' Current Deferred Revenue stood at $22.4 million in 2022, then surged by 49.42% to $33.4 million in 2023, then climbed by 11.1% to $37.1 million in 2024, then declined by 0.05% to $37.1 million in 2025, then climbed by 4.7% to $38.8 million in 2026.
• Business Quant data shows DLB's Current Deferred Revenue at $38.8 million in Q1 2026, $37.1 million in Q4 2025, and $31.4 million in Q3 2025.